Torres-Ferrús, Marta
Gallardo, Victor J.
Alpuente, Alicia
Caronna, Edoardo
Gine-Cipres, Eulalia
Pozo-Rosich, Patricia
Article History
Received: 2 February 2021
Revised: 12 March 2021
Accepted: 13 March 2021
First Online: 27 March 2021
Declarations
:
: Marta Torres-Ferrus has received honoraria as a consultant or speaker for Allergan-Abbvie, Almirall, Chiesi, Eli Lilly, Novartis and Teva. Alpuente A has received honoraria from Allergan plc, Novartis, Chiesi. Cipres-Gine E has received honoraria from Eli Lilly, Novartis and Teva. Victor J and Caronna E reports no diclosures. Pozo-Rosich P has received honoraria as a consultant and speaker for: Allergan-Abbvie, Almirall, Amgen, Biohaven, Chiesi, Eli Lilly, Medscape, Neurodiem, Novartis and Teva. Her research group has received research grants from Allergan, and has received funding for clinical trials from Alder, Allergan-Abbvie, Electrocore, Eli Lilly, Novartis and Teva. She is a trustee member of the board of the International Headache Society, member of the Council of the European Headache Society. She is in the editorial board of Revista de Neurologia, associate editor for Cephalalgia, Headache, Neurologia, Frontiers of Neurology and The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of ExternalRef removed. Pozo-Rosich P does not own stocks from any pharmaceutical company.
: Subjects’ consent was obtained according to the Declaration of Helsinki. The study was approved by Vall d’Hebron Ethics Committee.
: Patients gave their consent for participation.
: Patients gave their consent for publication.